C4 Therapeutics Inc Sustainability Reports
C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops targeted protein degradation therapies for the treatment of cancer and other difficult-to-treat diseases. The company leverages its proprietary TORPEDO platform to design small-molecule medicines that harness the body's natural protein recycling system.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00BV2Y9C6
3 reports from 2021 to 2024
